MediGene Concludes Agreement with Juste for the Commercialization of Veregen in Spain and Portugal
MediGene to receive milestone payments totalling up to 2,550,000 euro and royalties on future sales
25-Jun-2009 -
MediGene AG has entered into a marketing partnership with the Spanish company Juste S.A.Q.F. for the commercialization of Veregen® ointment (formerly Polyphenon E®) in Spain and Portugal. Juste will promote and distribute the drug for the treatment of genital warts. Depending on specified ...
Germany
milestone payments
Spain